In April of 2022, Global Coalition on Aging convened a cross-disciplinary and cross-sector group of global experts to consider public policy changes necessary for continued biomedical innovation that will enable 21^st century healthy longevity. The roundtable was convened by GCOA to take action in support of the global UN/WHO Decade of Healthy Ageing and in response to the proximate challenges to health and longevity highlighted by the COVID-19 pandemic. This roundtable and report were made possible by support from GCOA member Eli Lilly & Company.

The roundtable identified five key principles to frame how today’s and tomorrow’s health value propositions should be judged and four calls-to-action which would transform how health innovation is recognized and rewarded in order to foster healthy aging in the 21^st century.